- Home
- AIZ vs BMRN Comparison
AIZ vs BMRN Comparison
Compare AIZ & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIZ
- BMRN
- Stock Information
- Founded
- AIZ 1892
- BMRN 1996
- Country
- AIZ United States
- BMRN United States
- Employees
- AIZ N/A
- BMRN N/A
- Industry
- AIZ Property-Casualty Insurers
- BMRN Biotechnology: Pharmaceutical Preparations
- Sector
- AIZ Finance
- BMRN Health Care
- Exchange
- AIZ Nasdaq
- BMRN Nasdaq
- Market Cap
- AIZ 10.9B
- BMRN 10.0B
- IPO Year
- AIZ N/A
- BMRN 1999
- Fundamental
- Price
- AIZ $223.57
- BMRN $51.52
- Analyst Decision
- AIZ Buy
- BMRN Buy
- Analyst Count
- AIZ 6
- BMRN 19
- Target Price
- AIZ $243.00
- BMRN $90.26
- AVG Volume (30 Days)
- AIZ 300.4K
- BMRN 2.8M
- Earning Date
- AIZ 11-04-2025
- BMRN 10-27-2025
- Dividend Yield
- AIZ 1.43%
- BMRN N/A
- EPS Growth
- AIZ 17.16
- BMRN 59.53
- EPS
- AIZ 16.41
- BMRN 2.68
- Revenue
- AIZ $12,568,700,000.00
- BMRN $3,094,001,000.00
- Revenue This Year
- AIZ $7.85
- BMRN $13.32
- Revenue Next Year
- AIZ $4.82
- BMRN $7.51
- P/E Ratio
- AIZ $13.67
- BMRN $19.20
- Revenue Growth
- AIZ 6.92
- BMRN 12.39
- 52 Week Low
- AIZ $174.97
- BMRN $50.76
- 52 Week High
- AIZ $230.55
- BMRN $73.51
- Technical
- Relative Strength Index (RSI)
- AIZ 65.78
- BMRN 40.53
- Support Level
- AIZ $207.78
- BMRN $51.80
- Resistance Level
- AIZ $225.00
- BMRN $53.49
- Average True Range (ATR)
- AIZ 4.20
- BMRN 1.84
- MACD
- AIZ 1.11
- BMRN -0.08
- Stochastic Oscillator
- AIZ 88.56
- BMRN 12.58
About AIZ Assurant Inc.
Assurant Inc is a protection company that partners with the brands to safeguard and service connected devices, homes and automobiles. It operate in North America, Latin America, Europe and Asia Pacific through two operating segments: Global Lifestyle and Global Housing. Global Lifestyle: includes mobile device solutions (including extended service contracts, insurance policies and related services), extended service contracts and related services for consumer electronics and appliances, and financial services and other insurance products. Global Housing: includes lender-placed homeowners, manufactured housing and flood insurance, as well as voluntary manufactured housing, condominium and homeowners insurance. Key revenue is generated from Global Lifestyle segment.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.